-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the evening of February 14, Jiu'an Medical announced that the company recently received a "Decision on Administrative Supervision Measures" ( Hereinafter referred to as the "Decision"), "Decision on Taking Regulatory Talk Measures against Liu Yi and Wu Tong" (Jin Zheng Jian Measures [2022] No.
The content of the Decision Letter is announced as follows:
I.
After investigation, on January 7, 2022, Tianjin Jiu'an Medical Electronics Co.
Liu Yi, as the chairman and general manager of Jiu'an Medical, and Wu Tong, as the secretary of the board of directors of Jiu'an Medical, are mainly responsible for the completeness of the information disclosure of the temporary report of the listed company
If you are not satisfied with these supervisory and administrative measures, you may file an application for administrative reconsideration with the China Securities Regulatory Commission within 60 days from the date of receipt of this decision, or you may file an application with the competent people within 6 months from the date of receipt of this decision.
